- Home
- BSET vs CGEN Comparison
BSET vs CGEN Comparison
Compare BSET & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSET
- CGEN
- Stock Information
- Founded
- BSET 1902
- CGEN 1993
- Country
- BSET United States
- CGEN Israel
- Employees
- BSET N/A
- CGEN N/A
- Industry
- BSET Home Furnishings
- CGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BSET Consumer Discretionary
- CGEN Health Care
- Exchange
- BSET Nasdaq
- CGEN Nasdaq
- Market Cap
- BSET 134.7M
- CGEN 142.4M
- IPO Year
- BSET 1987
- CGEN 2000
- Fundamental
- Price
- BSET $14.38
- CGEN $2.30
- Analyst Decision
- BSET
- CGEN Strong Buy
- Analyst Count
- BSET 0
- CGEN 1
- Target Price
- BSET N/A
- CGEN $4.00
- AVG Volume (30 Days)
- BSET 10.6K
- CGEN 896.7K
- Earning Date
- BSET 01-31-2025
- CGEN 03-04-2025
- Dividend Yield
- BSET 5.69%
- CGEN N/A
- EPS Growth
- BSET N/A
- CGEN N/A
- EPS
- BSET N/A
- CGEN 0.02
- Revenue
- BSET $340,285,000.00
- CGEN $59,852,000.00
- Revenue This Year
- BSET N/A
- CGEN $57.27
- Revenue Next Year
- BSET $1.77
- CGEN N/A
- P/E Ratio
- BSET N/A
- CGEN $125.59
- Revenue Growth
- BSET N/A
- CGEN 698.03
- 52 Week Low
- BSET $12.11
- CGEN $1.35
- 52 Week High
- BSET $16.50
- CGEN $3.03
- Technical
- Relative Strength Index (RSI)
- BSET 56.27
- CGEN 82.82
- Support Level
- BSET $13.66
- CGEN $2.13
- Resistance Level
- BSET $14.47
- CGEN $2.45
- Average True Range (ATR)
- BSET 0.30
- CGEN 0.16
- MACD
- BSET 0.06
- CGEN 0.07
- Stochastic Oscillator
- BSET 89.27
- CGEN 84.54
About BSET Bassett Furniture Industries Incorporated
Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment.
About CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902, bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.